Antiviral and antiproliferative effects of canine interferon-λ1

Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):141-6. doi: 10.1016/j.vetimm.2013.09.013. Epub 2013 Sep 27.

Abstract

Interferon (IFN)-λs, members of the type III IFN group, were recently identified in several vertebrates. Although IFN-λs have the potential to be utilized as antiviral and antitumor agents in veterinary medicine, the biological properties of IFN-λs have not yet been studied in companion animals. In this study, we analyzed the expression of canine IFN-λs and their receptors, produced a recombinant canine IFN-λ1 protein, and investigated its antiviral and antiproliferative activities using a canine kidney epithelial cell line, MDCK cells. MDCK cells were found to express type III IFN molecules, IFN-λ1 and IFN-λ3, and the receptors, IFNλR1 and IL10R2. IFN-λ1 was induced faster than IFN-λ3 by stimulation with poly (I:C). His-tagged IFN-λ1 protein expressed in Escherichia coli inhibited cytolytic plaque formation by influenza A virus infection, and induced the expression of interferon-stimulated genes, Mx1 and OAS1, in MDCK cells. In addition, recombinant IFN-λ1 inhibited the proliferation of MDCK cells slightly. These effects were observed in a dose-dependent manner. These results indicate that canine IFN-λ1 has antiviral effect, and suggest the potential applicability of canine IFN-λ1 as a therapeutic agent.

Keywords: Antiproliferation; Antiviral activity; Dog; IFN-λ1; Interferon-stimulated genes.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antiviral Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cloning, Molecular
  • Dogs
  • Humans
  • Interferon-gamma / genetics
  • Interferon-gamma / pharmacology*
  • Molecular Sequence Data
  • Recombinant Proteins / pharmacology

Substances

  • Antiviral Agents
  • Recombinant Proteins
  • Interferon-gamma